Workflow |
| Improving Disease Detection Through Intelligent Pap Imaging™ |
| |
 |
| |
| | Normal Population |
| | Abnormal Population |
| | Directed QC Technology™ Review |
|
| |
| A. |
Slides with scores below the primary threshold can be archived with no further review |
| B. | Slides with scores above the primary threshold are reviewed by cytotechnologists |
| C. | Slides with scores above the QC threshold are re-screened by cytotechnologists |
|
|
| |
- As each slide is scanned by the BD FocalPoint™ Slide Profiler, two algorithms rank each slide based on abnormality.
|
- Slides that are designated as Review are prioritized based on the risk for abnormality to aid the Cytotechnologist and the Pathologist in diagnosis and quality control.
|
|
 |
- BD FocalPoint™ Slide Profiler uses proprietary imaging algorithms to detect both glandular and squamous abnormalities.
|
- BD FocalPoint™ Slide Profiler identifies at least 15% of all successfully processed slides for a Directed QC Technology™, satisfying CLIA 88 QC Re-screen guidelines.
|
- The QC review slides are subject to 3 screening events to reduce the potential of false-negatives: BD FocalPoint™ screen, Cytotechnologist screen, and QC re-screen.
|
|
| |
| Click here to see the benefits of the BD FocalPoint™ Slide Profiler. |
